Botulinum toxin to control an incapacitating tic in a child with a clavicular fracture

Anaesthesia and Intensive Care

Volumn 38, Issue 6, 2010, Pages 1106-1108

  Chen, Yu Ping ^a   Thalayasingam, P ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Botulinum toxin; Tic suppression therapy

Indexed keywords

BOTULINUM TOXIN A; CLONIDINE; DIAZEPAM; IBUPROFEN; KETAMINE; MORPHINE; PARACETAMOL; RISPERIDONE; TETRABENAZINE; TRAMADOL;

ADJUVANT THERAPY; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CHILD; CLAVICLE FRACTURE; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DYSESTHESIA; FOLLOW UP; FRACTURE HEALING; HALLUCINATION; HEMATOMA; HUMAN; MALE; MOTOR ACTIVITY; NECK PAIN; NIGHTMARE; OPEN REDUCTION; OSTEOSYNTHESIS; PARALYSIS; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE COMPLICATION; SCHOOL CHILD; TIC; WOUND DEHISCENCE; WRITHING TEST;

EID: 78650479815     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1003800624     Document Type: Article

References (14)

1. Shprecher D, Kurlan R. The management of tics. Mov Disord 2009; 24:15-24.
2. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 1994; 9:347-349.
3. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005; CD003633.
4. Swope D, Barbano R. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin 2008; 26:54-65.
5. Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E et al. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord 2010; 16:316-323.
6. Vincent DA. Botulinum toxin in the management of laryngeal tics. J Voice 2008; 22:251-256.
7. Srirompotong S, Saeseow P, Kharmwan S, Srirompotong S. Ear wiggling tics: treatment with botulinum toxin injection. Eur Arch Otorhinolaryngol 2007; 264:385-387.
8. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000; 57:1190-1193.
9. Porta M, Maggioni G, Ottaviani F, Schindler A. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci 2004; 24:420-423.
10. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind controlled clinical trial. Neurology 2001; 56:605-610.
11. Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Pascual-Sedano B, Gironell A, Kulisevsky J. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord 2008; 14:443-445.
12. Adler CH, Zimmerman RS, Lyons MK, Simeone F, Brin MF. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord 1996; 11:79-81.
13. Sojer M, Wissel J, Muller J, Poewe W. [Treatment of focal dystonia with botulinum toxin A]. Wien Klin Wochenschr 2001; 113:S6-10.
14. Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699-1706.